Online inquiry

IVTScrip™ mRNA-Human ARRDC3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25080MR)

This product GTTS-WK25080MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARRDC3 protein. This product can be used in Mitotic arrest phase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001329670.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 57561
UniProt ID Q96B67
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARRDC3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25080MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25353MR IVTScrip™ mRNA-Human ARMC2, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ARMC2
GTTS-WK19357MR IVTScrip™ mRNA-Human AMOTL2, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AMOTL2
GTTS-WK28637MR IVTScrip™ mRNA-Human ARL16, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARL16
GTTS-WK6293MR IVTScrip™ mRNA-Human GPR44, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA GPR44
GTTS-WK18321MR IVTScrip™ mRNA-Human AHI1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AHI1
GTTS-WK12845MR IVTScrip™ mRNA-Human ADGRL1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ADGRL1
GTTS-WK8782MR IVTScrip™ mRNA-Human ABRACL, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ABRACL
GTTS-WK2077MR IVTScrip™ mRNA-Human CD63, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA CD63
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →